Verapamil Therapy
Verapamil Therapy is a pharmacological intervention within antiarrhythmic therapy that utilizes the L-type calcium channel blocker verapamil to selectively suppress abnormal cardiac conduction, particularly in supraventricular arrhythmias, by decreasing sinoatrial and atrioventricular nodal excitability.
2.3K
Publications
112.5K
Citations
8.6K
Authors
1.9K
Institutions
Publications per year
2017–2026
123
Parents
2.3K
1–5 of 2.3K
8.6K
24
h-index
18
h-index
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Germany
17 publications · 1.3K citations
16
h-index
National Heart Lung and Blood Institute, United States
15 publications · 2.1K citations
14
h-index
National Heart Lung and Blood Institute, United States
14 publications · 2.3K citations
14
h-index
1–5 of 8.6K
1.9K
University of Florida
Gainesville, United States
23 h-index
171 publications
20.2K citations
Florida College
Temple Terrace, United States
19 h-index
105 publications
8.4K citations
Harvard University
Cambridge, United States
18 h-index
71 publications
3.8K citations
University of California, San Francisco
San Francisco, United States
18 h-index
88 publications
5.8K citations
Baylor College of Medicine
Houston, United States
16 h-index
68 publications
2.1K citations
The University of Texas Southwestern Medical Center
Dallas, United States
15 h-index
69 publications
3.6K citations

University of Toronto
Toronto, Canada
15 h-index
57 publications
2.3K citations
Albert Einstein College of Medicine
Bronx, United States
15 h-index
81 publications
4.3K citations
1–8 of 1.9K
81 publications · 10K citations
53
h-index
117 publications · 7.3K citations
50
h-index
Repository · 251 publications · 9.5K citations
44
h-index
CPT · 54 publications · 3.2K citations
32
h-index
78 publications · 2.5K citations
29
h-index
1–5